Parkinson Disease (diet therapy) < Parkinson Disease (drug therapy) < Parkinson Disease (economics)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 472.
[40-60] [0 - 20][0 - 50][60-80]

Ident.	Authors (with country if any)	Title
000174 (2001)	F. Durif [France] ; I. Devaux ; J J Pere ; J C Delumeau ; I. Bourdeix	Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study.
000182 (2001)	S. Descombes [France] ; A M Bonnet ; U E Gasser ; C. Thalamas ; J. Dingemanse ; I. Arnulf ; M P Bareille ; Yves Agid [France] ; O. Rascol	Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease.
000183 (2001)	O. Rascol [France] ; N. Fabre ; C. Brefel-Courbon ; J L Montastruc	The pharmacologic treatment of gait ignition failure.
000189 (????)	J L Montastruc [France] ; C. Brefel-Courbon ; J M Senard ; H. Bagheri ; J. Ferreira ; O. Rascol ; M. Lapeyre-Mestre	Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study.
000191 (2001)	J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-Courbon	Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
000197 (2001)	F. Maurel [France] ; H. Lilliu ; C. Le Pen	[Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
000199 (2000)		Pergolide and Parkinson's disease: new preparation. No clear benefit.
000200 (2001)	O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France]	Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
000202 (2001)	E. Bezard [France] ; J M Brotchie ; C E Gross	Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.
000206 (2001)	M. Peschanski	[10 years of substitution therapy for neurodegenerative diseases using fetal neuron grafts: a positive outcome but with questions for the future].
000208 (2001)	O. Rascol [France] ; J J Ferreira ; C. Thalamas ; M. Galitsky ; J L Montastruc	Dopamine agonists. Their role in the management of Parkinson's disease.
000223 (2002)	Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta Imperato	Neuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000224 (2002)	Luc J P. Defebvre [France] ; Pierre Krystkowiak ; Jean-Louis Blatt ; Alain Duhamel ; Jean-Louis Bourriez ; Myriame Périna ; Serge Blond ; Jean-Daniel Guieu ; Alain Destée [France]	Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease.
000227 (2001)	O. Rascol [France] ; J. Ferreira ; J L Montastruc	[Abnormal diurnal somnolence, "sleep attacks" and antiparkinson drugs].
000234 (2002)	I. Arnulf [France] ; E. Konofal ; M. Merino-Andreu ; J L Houeto ; V. Mesnage ; M L Welter ; L. Lacomblez ; J L Golmard ; J P Derenne ; Yves Agid [France]	Parkinson's disease and sleepiness: an integral part of PD.
000239 (2002)	Paul Krack [France] ; Valérie Fraix ; Alexandre Mendes ; Alim-Louis Benabid ; Pierre Pollak	Postoperative management of subthalamic nucleus stimulation for Parkinson's disease.
000240 (2002)	Christelle Gouhier [France] ; Sylvie Chalon ; Anne Aubert-Pouessel ; Marie-Claire Venier-Julienne ; Christophe Jollivet ; Jean-Pierre Benoit ; Denis Guilloteau	Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
000242 (2002)	M. Bailbé ; S. Karolewicz ; J Ph Neau ; P. Dumas ; R. Gil	[Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
000244 (2002)		Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
000245 (2001)	J. Xie [France] ; P. Krack ; A L Benabid ; P. Pollak	Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait.
000252 (2002)	P. Krystkowiak [France] ; L. Defebvre	[Rush dyskinesia scale or Goetz scale].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (drug therapy)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024